Diabetologia
Comparative hepatic effectiveness of empagliflozin vs dapagliflozin among individuals with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
Cohort study of 265,098 peopleInterventions
- Empagliflozin
- Type 2 diabetes
- Metabolic dysfunction-associated steatotic liver disease
- Fatty liver index
- Humans
The paper
Sungkyunkwan University; National University College
Diabetologia, 30 Sep 2026
